Gene editing company Intellia Therapeutics Wednesday announced it plans to sell 5 million shares at $16 to $18 in an initial public offering.
Forex – financial instrument.Forex news
Gene editing company Intellia Therapeutics Wednesday announced it plans to sell 5 million shares at $16 to $18 in an initial public offering.